Stephan Toutain
Chief Operating Officer at PDS BIOTECHNOLOGY CORPORATION
Stephan Toutain active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Chief Operating Officer | 2024-04-30 | - |
Career history of Stephan Toutain
Former positions of Stephan Toutain
| Companies | Position | Start | End |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Chief Operating Officer | 2018-03-04 | 2024-03-31 |
| INTERLEUKIN GENETICS, INC | Corporate Officer/Principal | 2016-06-30 | 2017-07-31 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2013-12-31 | 2014-12-31 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2008-12-31 | 2010-12-31 |
Training of Stephan Toutain
| Nancy-Université | Graduate Degree |
| The University of North Carolina at Charlotte | Masters Business Admin |
Statistics
International
| United States | 7 |
| France | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| ANAVEX LIFE SCIENCES CORP. | Health Technology |
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Stephan Toutain
- Experience
